Fluocinolone acetonide
Systematic (IUPAC) name | |
---|---|
(1S,2S,4R,8S,9S,11S,12R,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy cat. | C |
Legal status | Prescription Only |
Routes | Topical |
Pharmacokinetic data | |
Metabolism | Hepatic, CYP3A4-mediated |
Half-life | 1.3 to 1.7 hours |
Identifiers | |
CAS number | 67-73-2 |
ATC code | C05AA10 D07AC04 S01BA15 S02BA08 |
PubChem | CID 6215 |
DrugBank | DB00591 |
ChemSpider | 5980 |
UNII | 0CD5FD6S2M |
KEGG | D01825 |
ChEMBL | CHEMBL989 |
Chemical data | |
Formula | C24H30F2O6 |
Mol. mass | 452.488 g/mol |
SMILES
| |
| |
(what is this?) (verify) | |
Fluocinolone acetonide is a corticosteroid primarily used in dermatology to reduce skin inflammation and relieve itching. It is a synthetic hydrocortisone derivative. The fluorine substitution at position 9 in the steroid nucleus greatly enhances its activity. A typical dosage strength used in dermatology is 0.01–0.025%. One such cream is sold under the brand name Flucort-N and includes the antibiotic neomycin.
Flucinolone is a group IV corticosteroid under US classification.
See also
References
|
|
|